首页|National report on healthcare utilization and mortality in patients with hepatitis A infection in the United States
National report on healthcare utilization and mortality in patients with hepatitis A infection in the United States
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NSTL
Elsevier
Objectives: Predictors of negative outcomes related to hepatitis A virus (HAV) need to be studied at a national level. Study design and Methods: A retrospective analysis using the Nationwide Inpatient Sample (2002-2013) and Nationwide Readmission Database (2010-2014) was performed to evaluate the outcomes of hospitalized patients with HAV. The Nationwide Inpatient Sample and the Nationwide Readmission Database included a varying number of states during the studied time and reflect the range of implementation dates of the HAV vaccines. Multivariable analyses were fit to determine predictors of outcomes. Results: A total of 13,514 patients were admitted with HAV during the studied time. Thirty-day and 90day readmission rates were 11.4% and 15%, respectively. Predictors of readmission, longer length of stay, and mortality included patients aged >60 years ([odds ratio [OR]: 1.02; 95% confidence interval [CI]: 1.001-1.03], [OR: 1.15; CI: 1.07-1.24], [OR: 4.06; 95% CI: 1.47-11.16], respectively), Medicare insurance ([OR:3.63; 95% CI: 2.18-6.03], [OR: 1.26; 95% CI: 1.17-1.37], [OR: 2.67; 95% CI: 1.18-6.04], respectively), and cirrhosis ([OR: 1.83; 95% CI: 1.05-3.21], [OR: 1.33; 95% CI: 1.20-1.47], [OR: 2.83; 95% CI: 1.14-7.05], respectively). Predictors of higher cost of admission included patients aged >60 years (OR: 1.32, 95% CI: 1.19-1.46), Hispanic (OR: 1.14; 95% CI: 1.05-1.24), Medicare insurance (OR: 1.22; 95% CI: 1.10-1.35), Medicaid insurance (OR: 1.10; 95% CI: 1.02-1.20), and cirrhosis (OR: 1.28; 95% CI: 1.11-1.46). Conclusions: Patients at increased healthcare utilization and mortality should be prioritized for HAV vaccination.
Hepatitis A virusHealthcare utilizationMortalityHealthcare disparitiesCirrhosisVaccinationVIRAL-HEPATITISVIRUS-INFECTIONLIVER-FAILUREEPIDEMIOLOGY
Sobotka, L. A.、Mumtaz, K.、Hinton, A.、Porter, K.、Conteh, L. F.
展开 >
Gastroenterol Hepatol & Nutr,Ohio State Wexner Med Ctr
NSTL
Elsevier
